Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Segment Anything foundation model achieves favorable brain tumor auto-segmentation accuracy in MRI to support radiotherapy treatment planning.
Putz F, Beirami S, Schmidt MA, May MS, Grigo J, Weissmann T, Schubert P, Höfler D, Gomaa A, Hassen BT, Lettmaier S, Frey B, Gaipl US, Distel LV, Semrau S, Bert C, Fietkau R, Huang Y. Putz F, et al. Among authors: weissmann t. Strahlenther Onkol. 2024 Nov 6. doi: 10.1007/s00066-024-02313-8. Online ahead of print. Strahlenther Onkol. 2024. PMID: 39503868
German radiation oncology's next generation: a web-based survey of young biologists, medical physicists, and physicians-from problems to solutions.
Weissmann T, Deloch L, Grohmann M, Trommer M, Fabian A, Ehret F, Stefanowicz S, Rühle A, Lettmaier S, Putz F, Shariff M, Wegen S, Matschke J, Sperk E, Schröder A. Weissmann T, et al. Strahlenther Onkol. 2024 Dec;200(12):1005-1024. doi: 10.1007/s00066-024-02305-8. Epub 2024 Oct 22. Strahlenther Onkol. 2024. PMID: 39436419 Free PMC article.
Defining intra-tumoral and systemic immune biomarkers for locally advanced head-and-neck cancer - detailed protocol of a prospective, observatory multicenter trial (ImmunBioKHT) and first results of the immunophenotyping of the patients' peripheral blood.
Donaubauer AJ, Frey B, Weber M, Allner M, Vogl C, Almajali O, Kuczera L, Tamse H, Balk M, Müller S, Eckstein M, Zülch L, Mogge L, Weissmann T, Fietkau R, Kesting M, Iro H, Gaipl US, Hecht M, Gostian AO. Donaubauer AJ, et al. Among authors: weissmann t. Front Oncol. 2024 Sep 13;14:1451035. doi: 10.3389/fonc.2024.1451035. eCollection 2024. Front Oncol. 2024. PMID: 39346733 Free PMC article.
Comprehensive multimodal deep learning survival prediction enabled by a transformer architecture: A multicenter study in glioblastoma.
Gomaa A, Huang Y, Hagag A, Schmitter C, Höfler D, Weissmann T, Breininger K, Schmidt M, Stritzelberger J, Delev D, Coras R, Dörfler A, Schnell O, Frey B, Gaipl US, Semrau S, Bert C, Hau P, Fietkau R, Putz F. Gomaa A, et al. Among authors: weissmann t. Neurooncol Adv. 2024 Jul 11;6(1):vdae122. doi: 10.1093/noajnl/vdae122. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39156618 Free PMC article.
Benchmarking ChatGPT-4 on a radiation oncology in-training exam and Red Journal Gray Zone cases: potentials and challenges for ai-assisted medical education and decision making in radiation oncology.
Huang Y, Gomaa A, Semrau S, Haderlein M, Lettmaier S, Weissmann T, Grigo J, Tkhayat HB, Frey B, Gaipl U, Distel L, Maier A, Fietkau R, Bert C, Putz F. Huang Y, et al. Among authors: weissmann t. Front Oncol. 2023 Sep 14;13:1265024. doi: 10.3389/fonc.2023.1265024. eCollection 2023. Front Oncol. 2023. PMID: 37790756 Free PMC article.
Deep Learning and Registration-Based Mapping for Analyzing the Distribution of Nodal Metastases in Head and Neck Cancer Cohorts: Informing Optimal Radiotherapy Target Volume Design.
Weissmann T, Mansoorian S, May MS, Lettmaier S, Höfler D, Deloch L, Speer S, Balk M, Frey B, Gaipl US, Bert C, Distel LV, Walter F, Belka C, Semrau S, Iro H, Fietkau R, Huang Y, Putz F. Weissmann T, et al. Cancers (Basel). 2023 Sep 18;15(18):4620. doi: 10.3390/cancers15184620. Cancers (Basel). 2023. PMID: 37760588 Free PMC article.
Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease control.
Willner A, Agaimy A, Fechner K, Ott O, Denz A, Weissmann T, Meidenbauer N, Höfler D, Gaipl U, Frey B, Schmidt M, Haller F, Horch R, Hartmann A, Grützmann R, Fietkau R, Semrau S. Willner A, et al. Among authors: weissmann t. Int J Hyperthermia. 2023;40(1):2248424. doi: 10.1080/02656736.2023.2248424. Int J Hyperthermia. 2023. PMID: 37611915 Free article.
41 results